Decreased expression of focal adhesion kinase is associated with a poor prognosis in extrahepatic bile duct carcinoma

Human Pathology

Volumn 41, Issue 6, 2010, Pages 859-866

  Hayashi, Akifumi ^a   Aishima, Shinichi ^a   Inoue, Takahiro ^a   Nakata, Kohei ^a   Morimatsu, Katsuya ^a   Nagai, Eishi ^a   Oda, Yoshinao ^a   Tanaka, Masao ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Dysplasia; Extrahepatic bile duct carcinoma; FAK; Poor prognosis

Indexed keywords

FOCAL ADHESION KINASE;

AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; EPITHELIUM; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; SURVIVAL RATE;

EID: 77951937648     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.09.018     Document Type: Article

References (35)

1. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 33-42
2. Michaud D.S. The epidemiology of pancreatic, gallbladder, and other biliary tract cancers. Gastrointest Endosc 56 (2002) S195-S200
3. Shimonishi T., Sasaki M., and Nakanuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7 (2000) 542-550
4. Verslype C., Prenen H., and Van Cutsem E. The role of chemotherapy in biliary tract carcinoma. HPB (Oxford) 10 (2008) 164-167
5. Schaller M.D., Borgman C.A., Cobb B.S., et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A 89 (1992) 5192-5196
6. Schaller M.D., Hildebrand J.D., Shannon J.D., et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14 (1994) 1680-1688
7. Xing Z., Chen H.C., Nowlen J.K., et al. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol Biol Cell 5 (1994) 413-421
8. Chen H.C., and Guan J.L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 91 (1994) 10148-10152
9. Zhang X., Chattopadhyay A., Ji Q.S., et al. Focal adhesion kinase promotes phospholipase C-gamma1 activity. Proc Natl Acad Sci U S A 96 (1999) 9021-9026
10. Han D.C., and Guan J.L. Association of focal adhesion kinase with Grb7 and its role in cell migration. J Biol Chem 274 (1999) 24425-24430
11. Cance W.G., Harris J.E., Iacocca M.V., et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 6 (2000) 2417-2423
12. Miyazaki T., Kato H., Nakajima M., et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 89 (2003) 140-145
13. Kim S.J., Park J.W., Yoon J.S., et al. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study. J Korean Med Sci 19 (2004) 710-715
14. Sood A.K., Coffin J.E., Schneider G.B., et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 165 (2004) 1087-1095
15. Carelli S., Zadra G., Vaira V., et al. Up-regulation of focal adhesion kinase in non-small cell lung cancer. Lung Cancer 53 (2006) 263-271
16. Itoh S., Maeda T., Shimada M., et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 10 (2004) 2812-2817
17. Gabriel B., zur Hausen A., Stickeler E., et al. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin Cancer Res 12 (2006) 2476-2483
18. Ohta R., Yamashita Y., Taketomi A., et al. Reduced expression of focal adhesion kinase in intrahepatic cholangiocarcinoma is associated with poor tumor differentiation. Oncology 71 (2006) 417-422
19. Nakanishi Y., Zen Y., Kondo S., et al. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol 39 (2008) 1153-1161
20. Japanese Society of Biliary Surgery. General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract. 5th ed. (2003), Kanehara Shuppan, Tokyo
21. Albores-Saavedra J., Henson D.E., and Klimstra D.S. Tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater. In: Rosai J. (Ed). Atlas of tumor pathology, 3rd series (2000), Armed Forces Institute of Pathology, Washington
22. Albores-Saavedra J., Scoazec J.C., Wittekind C., et al. Carcinoma of the gallbladder and extrahepatic bile duct. In: Hamilton S.R., and Aaltonen L.A. (Eds). World Health Organization classification of tumours (2000), Tumours of the Digestive System. IARC Press, Lyon 206-214
23. Wakai T., Shirai Y., Moroda T., et al. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103 (2005) 1210-1216
24. Hong S.M., Cho H., Lee O.J., et al. The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol 29 (2005) 1177-1183
25. Hong S.M., Kim M.J., Cho H., et al. Superficial vs deep pancreatic parenchymal invasion in the extrahepatic bile duct carcinomas: a significant prognostic factor. Mod Pathol 18 (2005) 969-975
26. Hong S.M., Hwang I., Song D.E., et al. Clinical and prognostic significances of nuclear and cytoplasmic KIT expressions in extrahepatic bile duct carcinomas. Mod Pathol 20 (2007) 562-569
27. Yoshikawa D., Ojima H., Iwasaki M., et al. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer 98 (2008) 418-425
28. Murakami S., Miyamoto M., Hida Y., et al. Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma. Br J Cancer 88 (2003) 1234-1238
29. Tamada S., Shibahara H., Higashi M., et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 12 (2006) 4257-4264
30. Lu Z., Jiang G., Blume-Jensen P., et al. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21 (2001) 4016-4031
31. Yano H., Mazaki Y., Kurokawa K., et al. Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol 166 (2004) 283-295
32. Kallergi G., Agelaki S., Markomanolaki H., et al. Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem 20 (2007) 977-986
33. Schaller M.D. FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration?. J Cell Biol 166 (2004) 157-159
34. Moissoglu K., and Gelman I.H. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J Biol Chem 278 (2003) 47946-47959
35. Ayaki M., Komatsu K., Mukai M., et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res 7 (2001) 3106-3112